Skip to main content
EQ
NASDAQ Life Sciences

Equillium Beats Q3 Estimates, Cash Runway Extended Into 2029

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.34
Mkt Cap
$83.699M
52W Low
$0.756
52W High
$3.54
52W Position info
77% above low
Off High info
62% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

EQ sits 77% above its 52-week low of $0.756 on light trading volume (0.3× avg).

Summary

Equillium posted a Q3 net loss of $4.58 million, or $0.04 per share, versus consensus of $5.89 million and $0.05 — a modest beat on both lines. Operating expenses came in at $5.05 million against a $6.14 million estimate, with R&D spending rising as EQ504 moved into the clinic. The company ended the quarter with $53.3 million in cash and says that funds operations into 2029, following the $20 million milestone tranche closed in late October. The real story is EQ504: first-in-human dosing started in October, proof-of-mechanism data is expected in Q2 2027, and a proof-of-concept ulcerative colitis study is planned for H2 2027 if those results support it. At a roughly $84 million market cap, the 2029 runway removes near-term financing risk and keeps the focus on that 2027 readout.

At the time of this announcement, EQ was trading at $1.34 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $83.7M. The 52-week trading range was $0.76 to $3.54. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

EQ - Latest Insights

EQ
Oct 26, 2026, 5:09 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.29
Real-time Price: $1.34 info
Change: +$0.050 (+4%) info
Market Cap: $83.699M info
EQ
Oct 26, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.12
Real-time Price: $1.34 info
Change: +$0.2197 (+20%) info
Market Cap: $83.699M info
EQ
Oct 05, 2026, 5:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.42
Real-time Price: $1.34 info
Change: -$0.080 (-6%) info
Market Cap: $83.699M info
EQ
Oct 05, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.51
Real-time Price: $1.34 info
Change: -$0.170 (-11%) info
Market Cap: $83.699M info
EQ
Aug 13, 2026, 4:20 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.01
Real-time Price: $1.34 info
Change: -$0.6686 (-33%) info
Market Cap: $83.699M info